| |
| |
|
| Insider
Information: |
Grey Michael G |
| Relationship: |
Executive Chairman, Di... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
48,571 |
|
|
Indirect Shares
|
1,011,794 |
|
|
| Direct
Value |
$4,133,319 |
|
|
|
Indirect Value
|
$1,043,884 |
|
|
| Total
Shares |
1,060,365 |
|
|
| Total
Value |
$5,177,203 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sgx Pharmaceuticals, Inc. |
SGXP |
President & CEO, Direc... |
|
0 |
2008-08-20 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2021-03-05 |
42,840 |
2008-03-05 |
0 |
Premium* |
|
|
Horizon Pharma, Inc. |
HZNP |
Director |
2023-10-06 |
0 |
2023-10-06 |
0 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
|
2021-01-15 |
5,731 |
2019-05-13 |
0 |
Premium* |
|
|
Mirum Pharmaceuticals, Inc. |
MIRM |
Director |
2023-09-14 |
0 |
2023-09-14 |
382,948 |
Premium* |
|
|
Reneo Pharmaceuticals, Inc. |
RPHM |
Executive Chairman, Di... |
2023-07-26 |
0 |
2023-07-26 |
628,846 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
86 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2016-02-22 |
4 |
AS |
$80.00 |
$600,000 |
D/D |
(7,500) |
26,250 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2016-02-22 |
4 |
OE |
$38.59 |
$289,425 |
D/D |
7,500 |
33,750 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2016-05-06 |
4 |
OE |
$0.00 |
$0 |
I/I |
5,258 |
5,258 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2016-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,510 |
27,760 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2017-05-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
13,953 |
19,211 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2017-05-03 |
4 |
D |
$15.12 |
$56,897 |
I/I |
(3,763) |
15,448 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2017-05-10 |
4 |
B |
$9.48 |
$94,800 |
I/I |
10,000 |
25,448 |
2.1 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2017-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,050 |
29,810 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2018-05-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
14,054 |
39,502 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2018-05-03 |
4 |
D |
$13.87 |
$52,567 |
I/I |
(3,790) |
35,712 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2018-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,300 |
34,110 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2019-05-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
15,320 |
51,032 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2019-05-03 |
4 |
D |
$26.54 |
$109,663 |
I/I |
(4,132) |
46,900 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2019-05-13 |
4 |
OE |
$16.84 |
$119,564 |
D/D |
7,100 |
7,100 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2019-05-13 |
4 |
AS |
$65.26 |
$376,138 |
D/D |
(5,760) |
1,340 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2019-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,430 |
38,540 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Executive Chairman |
• • – |
2019-07-22 |
4 |
A |
$0.00 |
$0 |
I/I |
7,948 |
289,198 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2019-08-12 |
4 |
OE |
$16.84 |
$58,940 |
D/D |
3,500 |
4,840 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2019-08-12 |
4 |
AS |
$91.20 |
$280,697 |
D/D |
(3,042) |
1,798 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2019-11-12 |
4 |
OE |
$16.84 |
$58,940 |
D/D |
3,500 |
5,298 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2019-11-12 |
4 |
AS |
$102.44 |
$311,622 |
D/D |
(3,042) |
2,256 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2020-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
4,256 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2020-05-02 |
4 |
OE |
$0.00 |
$0 |
I/I |
15,390 |
62,290 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2020-05-22 |
4 |
S |
$48.77 |
$513,505 |
D/D |
(10,530) |
0 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2020-05-22 |
4 |
OE |
$7.84 |
$82,555 |
D/D |
10,530 |
10,530 |
0 |
- |
|
86 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
